← All Amylyx Pharmaceuticals, INC filings

Amylyx Pharmaceuticals, INC Form 4 insider transactions

NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
Form 4: Amylyx Pharmaceuticals Co-CEO Joshua Cohen Reports Stock and Option Awards
Joshua Cohen, Co-CEO of Amylyx Pharmaceuticals, reports the acquisition of restricted stock units and stock options.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
Form 4: Amylyx Pharmaceuticals Co-CEO Justin B. Klee Receives Stock Awards
Co-CEO of Amylyx Pharmaceuticals, Justin B. Klee, reports the acquisition of restricted stock units and stock options.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
Form 4: Amylyx Pharmaceuticals' Chief Legal Officer Receives Stock and Option Awards
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, receives restricted stock units and stock options.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold 2,838 shares of common stock on February 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.